Based on the Replimune Group Inc stock forecast from 0 analysts, the average analyst target price for Replimune Group Inc is not available over the next 12 months. Replimune Group Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Replimune Group Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Replimune Group Inc’s stock price was EUR 12.70. Replimune Group Inc’s stock price has changed by +0.00% over the past week, +1.60% over the past month and +63.87% over the last year.
No recent analyst target price found for Replimune Group Inc
No recent average analyst rating found for Replimune Group Inc
Company Overview Replimune Group Inc
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts. Read Less
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system agai...Read More
Frequently Asked Questions About Replimune Group Inc (7R8:F) Stock
Stock Target Advisor's fundamental analysis for Replimune Group Inc's stock is Bearish.
Unfortunately we do not have enough data on 7R8:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 7R8:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 7R8:F's stock to indicate if its overvalued.
The last closing price of 7R8:F's stock was EUR 12.70.
The most recent market capitalization for 7R8:F is EUR 0.92B.
Unfortunately we do not have enough analyst data on 7R8:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Replimune Group Inc's stock.
As per our most recent records Replimune Group Inc has 331 Employees.
Replimune Group Inc's registered address is 500 Unicorn Park Drive, Woburn, MA, United States, 01801.
You can get more information about it from Replimune Group Inc's website at https://www.replimune.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Replimune Group Inc (7R8:F) Stock
Stock Target Advisor's fundamental analysis for Replimune Group Inc's stock is Bearish.
Unfortunately we do not have enough data on 7R8:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 7R8:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 7R8:F's stock to indicate if its overvalued.
The last closing price of 7R8:F's stock was EUR 12.70.
The most recent market capitalization for 7R8:F is EUR 0.92B.
Unfortunately we do not have enough analyst data on 7R8:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Replimune Group Inc's stock.
As per our most recent records Replimune Group Inc has 331 Employees.
Replimune Group Inc's registered address is 500 Unicorn Park Drive, Woburn, MA, United States, 01801.
You can get more information about it from Replimune Group Inc's website at https://www.replimune.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 7R8:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
